RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

  • RoundupsRoundups

    EU Regulatory Roundup: Swissmedic Creates Signal Notification Form in Change to 2020 Requirements

    Welcome to our European Regulatory Roundup, our weekly overview of the top EU   regulatory news.   Ireland Seeks Industry Input on Regulatory Plan Through to 2025   Ireland’s Health Products Regulatory Authority (HPRA) is seeking feedback to inform development of its strategic plan for 2021 to 2025. HPRA wants input on how the sectors it regulates will change in the next five to 10 years and feedback on how well it currently communicates with stakeholders.   ...
  • RoundupsRoundups

    Asia Regulatory Roundup: TGA Seeks Feedback on Requirements for Fecal Transplant Manufacturing Sites

    Welcome to our Asia Regulatory Roundup, our weekly overview of the top regulatory news in Asia.   TGA Seeks Feedback on Requirements for Fecal Transplant Manufacturing Sites   Australia’s Therapeutic Goods Administration (TGA) is seeking feedback on the quality standards it plans to impose on manufacturers of fecal microbiota transplant (FMT) products. TGA wants to know how the changes will affect the sector and whether the proposed 12-month transition period is ...
  • RoundupsRoundups

    EU Regulatory Roundup: Health Group Raises Concerns About Delays to Clinical Trial Portal and Database

    Welcome to our European Regulatory Roundup, our weekly overview of the top EU   regulatory news.   EU Health Group Raises Concerns About Delays to Clinical Trial Portal and Database   The European Parliament’s public health committee has raised concerns about the delayed rollout of a clinical trial portal and database. Committee members made the comments shortly after the European Medicines Agency (EMA) provided an update on the repeatedly delayed system.   W...
  • RoundupsRoundups

    Asia Regulatory Roundup: Industry Questions TGA’s Ability to Enforce Proposed Software Rules

    Welcome to our Asia Regulatory Roundup, our weekly overview of the top regulatory news in Asia.   Medtech Industry Questions TGA’s Ability to Enforce Proposed Software Rules   The medtech industry has questioned whether the Therapeutic Goods Administration (TGA) can ensure all Software as a Medical Device (SaMD) products are included in the Australian Register of Therapeutic Goods (ARTG).   TGA proposed mandating the inclusion of SaMD products in the ARTG when ...
  • RoundupsRoundups

    EU Regulatory Roundup: Swissmedic Details Plans to Align Combination Product Rules With EU

    Welcome to our European Regulatory Roundup, our weekly overview of the top EU   regulatory news.   Trade Group Calls for EU to Cut Review Times for ATMP Clinical Trial Filings   The Alliance for Regenerative Medicine (ARM) has called for Europe to streamline approval of clinical trials of advanced therapy medicinal products (ATMP). ARM wants regulatory agencies to cut review timelines and harmonize their approaches to support development of cell and gene therapie...
  • RoundupsRoundups

    Asia Regulatory Roundup: Pakistan Posts Draft Accelerated Approval Guidances

    Welcome to our Asia Regulatory Roundup, our weekly overview of the top regulatory news in Asia. Pakistan Posts Draft Accelerated Approval Guidelines in Flurry of Activity   The Drug Regulatory Authority of Pakistan (DRAP) has published draft guidance on its priority review and accelerated approval processes. DRAP released the guidelines alongside a clutch of other guidance documents covering topics including pharmacovigilance and post-registration variations.   ...
  • RoundupsRoundups

    EU Regulatory Roundup: Ireland’s HPRA Tracks 4-Fold Increase in Marketing Authorization Transfers

    Welcome to our European Regulatory Roundup, our weekly overview of the top EU   regulatory news.   Ireland’s HPRA Tracks 4-Fold Increase in Marketing Authorization Transfers   Ireland’s Health Products Regulatory Authority (HPRA) has reported an almost four-fold increase in its annual number of marketing authorization holder (MAH) transfers. The jump covers the run up to the date on which the United Kingdom was originally due to leave the European Union.   In...
  • RoundupsRoundups

    Asia Regulatory Roundup: India Plans to Bring All Medical Devices Under CDSCO Oversight in December

    Welcome to our Asia Regulatory Roundup, our weekly overview of the top regulatory news in Asia.   India Plans to Bring All Medical Devices Under CDSCO Oversight in December   The Indian government is planning to give the Central Drugs Standard Control Organization (CDSCO) oversight of the import, manufacture and sale of all medical devices in December. If finalized, the change would require many more medical device companies to seek certification and authorizatio...
  • RoundupsRoundups

    EU Regulatory Roundup: CHMP Questions Delay Novartis Gene Therapy Approval Timeline

    Welcome to our European Regulatory Roundup, our weekly overview of the top EU   regulatory news.   CHMP Questions Delay Novartis Gene Therapy Approval Timeline   Tougher than expected regulatory scrutiny has delayed Novartis’ efforts to bring its spinal muscular atrophy gene therapy Zolgensma to patients in Europe. Novartis had hoped to win approval by the end of the year, but now expects the Committee for Medicinal Products for Human Use (CHMP) to deliver its op...
  • RoundupsRoundups

    Asia Regulatory Roundup: Hong Kong Proposes Regulatory Framework for Cell and Gene Therapies

    Welcome to our Asia Regulatory Roundup, our weekly overview of the top regulatory news in Asia.   Hong Kong Proposes Regulatory Framework for Cell and Gene Therapies   Hong Kong has proposed legislation to create a regulatory framework for advanced therapy products (ATPs), such as interventions based on cells, genes and tissues. The plan is to amend existing laws to create licensing, labeling and record-keeping requirements for ATPs.   Work to update the law ...
  • RoundupsRoundups

    Asia Regulatory Roundup: Pakistan Seeks Expert to Help Harmonize Regulations With Global Best Practices

    Welcome to our Asia Regulatory Roundup, our weekly overview of the top regulatory news in Asia.   New Zealand Extends Timelines for Reporting Medical Device Adverse Events   The New Zealand Medicines and Medical Devices Safety Authority (Medsafe) has given companies more time to report adverse events involving their medical devices.   Under the old rules, manufacturers of medical devices had seven calendar days to report incidents of actual or potential death...
  • RoundupsRoundups

    Asia Regulatory Roundup: TGA Offers Advice on Managing Shortages Triggered by Ranitidine Recalls

    Welcome to our Asia Regulatory Roundup, our weekly overview of the top regulatory news in Asia.   TGA Offers Advice on Managing Shortages Triggered by Ranitidine Recalls   Australia’s Therapeutic Goods Administration (TGA) has advised physicians about how to manage the shortages created by recalls of ranitidine medicines. The notice follows decisions by eight companies to recall batches of ranitidine medicines in response to contamination concerns.   TGA firs...